Timing of operation for poor-grade aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3751917)

Published in BMC Neurol on August 19, 2013

Authors

Qiao Zhang, Lu Ma, Yi Liu, Min He, Hong Sun, Xiang Wang, Yuan Fang, Xu-hui Hui, Chao You

Articles cited by this

International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet (2005) 10.00

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke (2012) 5.13

Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery (2002) 1.76

Poor-grade aneurysmal subarachnoid hemorrhage: outcome after treatment with urgent surgery. Neurosurgery (2003) 1.73

The risk of rebleeding from ruptured intracranial aneurysms. J Neurosurg (1987) 1.68

Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study. J Neurosurg (1989) 1.62

A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke (2000) 1.45

Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke (1993) 1.34

Study of aneurysmal subarachnoid hemorrhage in Izumo City, Japan. Stroke (1995) 1.21

Subarachnoid hemorrhage: aneurysm detection and preoperative evaluation with CT angiography. Radiology (1998) 1.11

Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol (1987) 1.10

Intracranial aneurysm surgery and its future. J R Soc Med (2003) 1.09

Aneurysmal rupture during angiography. Neurosurgery (1993) 1.08

Outcome from poor grade aneurysmal subarachnoid haemorrhage--which poor grade subarachnoid haemorrhage patients benefit from aneurysm clipping? Br J Neurosurg (2000) 1.03

Timing of surgery for supratentorial aneurysmal subarachnoid haemorrhage: report of a prospective study. J Neurol Neurosurg Psychiatry (2002) 0.98

What are the actual incidence and mortality rates of subarachnoid hemorrhage? Surg Neurol (1997) 0.94

Surgical management of traumatic intracranial pseudoaneurysms: a report of 12 cases. Neurol India (2008) 0.91

Preoperative prediction of outcome in 283 poor-grade patients with subarachnoid hemorrhage: a project of the Chugoku-Shikoku Division of the Japan Neurosurgical Society. Cerebrovasc Dis (2010) 0.90

Timing of aneurysm surgery in subarachnoid haemorrhage--an observational study in The Netherlands. Acta Neurochir (Wien) (2005) 0.89

Neurological grades of patients with poor-grade subarachnoid hemorrhage improve after short-term pretreatment. Neurosurgery (2000) 0.89

The natural history of intracranial aneurysms: rebleeding rates during the acute and long term period and implication for surgical management. Clin Neurosurg (1977) 0.86

Treatment of ruptured intracranial aneurysms: our approach. Minim Invasive Neurosurg (2005) 0.83

[Risk factors of cerebral aneurysm re-rupture during angiography]. No Shinkei Geka (1985) 0.83

Management morbidity and mortality in grade IV and V patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) (1990) 0.83

[Clinical characteristics of contrast medium extravasation from intracranial aneurysms during cerebral angiography: studies on personal experience and review of the literature]. No Shinkei Geka (1986) 0.82

Timing of aneurysm surgery: the International Cooperative Study revisited in the era of endovascular coiling. J Neurointerv Surg (2010) 0.82

Treatment of patients with intracranial arterial aneurysms in the haemorrhagic period. Neurol Res (1994) 0.79

Nimodipine treatment in poor-grade aneurysm patients. J Neurosurg (1988) 0.78

Timing of aneurysm surgery. Comparison of results of early and delayed surgical intervention. Eur Arch Psychiatry Neurol Sci (1988) 0.78

Effect of ultra-early referral on management outcome in subarachnoid haemorrhage. Acta Neurochir (Wien) (1995) 0.77

Analysis of 223 ruptured intracranial aneurysms with special reference to rerupture. Surg Neurol (1984) 0.77

Articles by these authors

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet (2008) 6.93

KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60

The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature (2012) 5.61

The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell (2008) 5.58

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol (2006) 5.41

mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science (2010) 4.81

Attenuated cold sensitivity in TRPM8 null mice. Neuron (2007) 4.73

Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science (2005) 4.58

Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature (2007) 4.54

Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis (2002) 4.23

Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol (2004) 3.97

Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS One (2006) 3.91

White Collar-1, a circadian blue light photoreceptor, binding to the frequency promoter. Science (2002) 3.85

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc Natl Acad Sci U S A (2006) 3.83

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83

CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat Cell Biol (2006) 3.49

Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke (2007) 3.46

Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature (2010) 3.39

Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nat Med (2010) 3.26

R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proc Natl Acad Sci U S A (2007) 3.24

The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat Chem Biol (2010) 3.15

Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol (2005) 3.12

MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle (2009) 3.07

Single reconstituted neuronal SNARE complexes zipper in three distinct stages. Science (2012) 2.98

Prestin-based outer hair cell motility is necessary for mammalian cochlear amplification. Neuron (2008) 2.98

White collar-1, a DNA binding transcription factor and a light sensor. Science (2002) 2.97

Allosteric inhibitors of Bcr-abl-dependent cell proliferation. Nat Chem Biol (2006) 2.96

Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod (2008) 2.95

Identifying the proteins to which small-molecule probes and drugs bind in cells. Proc Natl Acad Sci U S A (2009) 2.94

CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. Mol Cell (2002) 2.92

An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest (2009) 2.86

Structure of the human glucagon class B G-protein-coupled receptor. Nature (2013) 2.86

Practical reconstruction method for bioluminescence tomography. Opt Express (2005) 2.83

Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet (2004) 2.66

Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med (2010) 2.65

A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A (2007) 2.60

Extracellular polysaccharides mediate pilus retraction during social motility of Myxococcus xanthus. Proc Natl Acad Sci U S A (2003) 2.56

A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun (2005) 2.55

PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome. Nat Commun (2010) 2.54

CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett (2007) 2.43

Pure spinal epidural cavernous hemangioma. Acta Neurochir (Wien) (2012) 2.38

Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol (2009) 2.37

L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle (2006) 2.37

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog (2009) 2.36

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol (2007) 2.35

Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano (2012) 2.35

A general strategy for creating "inactive-conformation" abl inhibitors. Chem Biol (2006) 2.27

Diverse pathways generate microRNA-like RNAs and Dicer-independent small interfering RNAs in fungi. Mol Cell (2010) 2.23

Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol (2008) 2.23

A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat Chem Biol (2009) 2.21

Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol (2005) 2.17

Non-optimal codon usage affects expression, structure and function of clock protein FRQ. Nature (2013) 2.15

SVA: software for annotating and visualizing sequenced human genomes. Bioinformatics (2011) 2.11

Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J (2007) 2.07

Regulation of the Neurospora circadian clock by an RNA helicase. Genes Dev (2004) 2.07

qiRNA is a new type of small interfering RNA induced by DNA damage. Nature (2009) 2.06

Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models. PLoS One (2012) 2.01

Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy. J Gastroenterol (2015) 2.01

Biocompatible copper(I) catalysts for in vivo imaging of glycans. J Am Chem Soc (2010) 1.98

Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol (2004) 1.96

Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci (2002) 1.96

The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering. J Endod (2008) 1.95

Spontaneous spinal epidural hematoma: analysis of 23 cases. Surg Neurol (2007) 1.94

Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology (2010) 1.93

FWD1-mediated degradation of FREQUENCY in Neurospora establishes a conserved mechanism for circadian clock regulation. EMBO J (2003) 1.89

Molecular mechanism of light responses in Neurospora: from light-induced transcription to photoadaptation. Genes Dev (2005) 1.89

QIP, a putative exonuclease, interacts with the Neurospora Argonaute protein and facilitates conversion of duplex siRNA into single strands. Genes Dev (2007) 1.88

DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites. Biotechniques (2010) 1.88

Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients. Biol Psychiatry (2011) 1.87

The Neurospora crassa circadian clock. Adv Genet (2007) 1.86

Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolytic. J Am Chem Soc (2012) 1.86

Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat Commun (2012) 1.85

CKI and CKII mediate the FREQUENCY-dependent phosphorylation of the WHITE COLLAR complex to close the Neurospora circadian negative feedback loop. Genes Dev (2006) 1.85

Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells. Clin Cancer Res (2006) 1.85

Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. Environ Sci Technol (2010) 1.84

The COP9 signalosome regulates the Neurospora circadian clock by controlling the stability of the SCFFWD-1 complex. Genes Dev (2005) 1.83

PAS domain-mediated WC-1/WC-2 interaction is essential for maintaining the steady-state level of WC-1 and the function of both proteins in circadian clock and light responses of Neurospora. Mol Cell Biol (2002) 1.82

Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression. Hepatology (2015) 1.81

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet (2012) 1.78

Can graphene be used as a substrate for Raman enhancement? Nano Lett (2010) 1.78

Organization of the Caenorhabditis elegans small non-coding transcriptome: genomic features, biogenesis, and expression. Genome Res (2005) 1.77

Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano (2011) 1.75

Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet (2012) 1.72

Use of targetrons to disrupt essential and nonessential genes in Staphylococcus aureus reveals temperature sensitivity of Ll.LtrB group II intron splicing. RNA (2006) 1.71

Poly[mu-aqua-mu4-naphthalene-1,8-dicarboxylato-zinc(II)]. Acta Crystallogr C (2007) 1.69

A radiopathological classification of dural tail sign of meningiomas. J Neurosurg (2012) 1.69

Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J Biol Chem (2004) 1.68

Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano (2011) 1.68

Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res (2013) 1.68

Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.68

The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies. PLoS Pathog (2013) 1.67

An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci (2010) 1.67

Increasing the efficacy of bioorthogonal click reactions for bioconjugation: a comparative study. Angew Chem Int Ed Engl (2011) 1.66

Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy. Clin Cancer Res (2012) 1.65

R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology (2007) 1.64

Convergent antibody signatures in human dengue. Cell Host Microbe (2013) 1.64